Table 2 Basic information on patients used for QRT-PCR validation
Disease name | Gender | Age | Complications | Time of onset(day) |
|---|---|---|---|---|
AMI-1 | Male | 58 | CHD、Hypertension | 5 |
AMI-2 | Male | 49 | CHD | 3 |
AMI-3 | Female | 38 | CHD | 4 |
AMI-4 | Male | 58 | Hypertension, T2DM | 1 |
AMI-5 | Female | 60 | CHD, Hypertension | 1 |
AMI-6 | Male | 72 | CHD | 1 |
COVID-19–1 | Male | 80 | CHD, Hypertension | 5 |
COVID-19–2 | Male | 79 | Hypertension | 1 |
COVID-19–3 | Female | 70 | Pneumonia, CHD | 4 |
COVID-19–4 | Male | 69 | Hypertension, T2DM | 8 |
COVID-19–5 | Male | 91 | Pneumonia, CHD | 5 |
AIS-1 | Male | 57 | Non | 2 |
AIS-2 | Male | 80 | T2DM | 3 |
AIS-3 | Female | 60 | Hypertension, T2DM | 8 |
AIS-4 | Male | 82 | Hypertension | 5 |
AIS-5 | Male | 62 | T2DM | 1 |
CHD: Coronary Heart Disease; T2DM: Type 2 Diabetes Mellitus | ||||